![Immunotherapy, precision medicine in lung cancer drive sharp decline in cancer mortality overall](https://cdn.cancerletter.com/media/2020/01/25191429/TCL46-02-lungs_4x3.jpg)
![Immunotherapy, precision medicine in lung cancer drive sharp decline in cancer mortality overall](https://cdn.cancerletter.com/media/2020/01/25191429/TCL46-02-lungs_4x3.jpg)
Cover Story
FreeGuest Editorial
As I look through just-published tables of age-adjusted cancer mortality, I recognize an unprecedented development:
By Alexandria Carolan
In Brief
Funding Opportunities
Clinical Roundup
Drugs & Targets
![Drugs & Targets](https://cdn.cancerletter.com/media/2019/05/03161633/targets2.jpg)
![Drugs & Targets](https://cdn.cancerletter.com/media/2019/05/03161633/targets2.jpg)
Trending Stories
- How a Georgetown med school student found her calling in surgery, law, and health equity
- Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Laurie Glimcher to step down as Dana-Farber president and CEO, Benjamin Levine Ebert named successor
- Lei Zheng got his PhD in San Antonio; now he returns as cancer center director at Mays
- As NCI’s appropriations stay flat, Rathmell keeps the FY26 bypass budget steady at just under $11.5B
Rathmell: “We understand that there are real economic constraints facing our country and the world. But our gap just can’t keep widening.” - Huiping Liu discusses mentorship, translational research on the UChicago Cancer Luminaries podcast